Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications
- 4 April 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 8 (14) , 8967-8979
Abstract
Currently there is a strong need for new drug delivery systems, which enable targeted and controlled function in delivering drugs while satisfying highly sensitive imaging modality for early detection of the disease symptoms and damaged sites. To meet these criteria we develop a novel system that integrates therapeutic and diagnostic capabilities (theranostic). Importantly, therapeutic efficacy of the system is enhanced by exploiting synergies between nanoparticles, drug and hyperthermia. At the core of our innovation is NIR-responsive gold nanorods (Au) coated with drug reservoirs – mesoporous silica shell (mSi) – that is capped with thermo-responsive polymer. Such design of theranostics allows the detection of the system using computed tomography (CT), while finely controlled release of the drug is achieved by external trigger, near infrared light (NIR) irradiation – ON/OFF switch. Doxorubicin (DOX) was loaded into mSi formed on the gold core (Au@mSi-DOX). Pores were then capped with the temperature sensitive poly(N-isopropylacrylamide)-based N-butyl imidazolium copolymer (poly(NIPAAm-co-BVIm)) resulting in a hybrid system – Au@mSi-DOX@P. A 5 min exposure to NIR induces polymer transition, which triggers the drug release (pores opening), increases local temperature above 43°C (hyperthermia) and upregulates particles uptake (polymer becomes hydrophilic). The DOX release is also triggered by drop in pH enabling localized drug release when particles are taken up by cancer cells. Importantly, the synergies between chemo- and photothermal-therapy for DOX-loaded theranostics were confirmed. Furthermore, higher x-ray attenuation value of the theranostics was confirmed via x-ray CT test indicating that the nanoparticles act as contrast agent and can be detected by CT.Keywords
Funding Information
- National Research Foundation of Korea (2009-0093829, 2015032163)
This publication has 61 references indexed in Scilit:
- Smart Albumin‐Biomineralized Nanocomposites for Multimodal Imaging and Photothermal Tumor AblationAdvanced Materials, 2015
- Integrating Oxaliplatin with Highly Luminescent Carbon Dots: An Unprecedented Theranostic Agent for Personalized MedicineAdvanced Materials, 2014
- Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugsActa Biomaterialia, 2014
- Using Fluorescence Lifetime Imaging Microscopy to Monitor Theranostic Nanoparticle Uptake and Intracellular Doxorubicin ReleaseACS Nano, 2013
- Multifunctional Compact Hybrid Au Nanoshells: A New Generation of Nanoplasmonic Probes for Biosensing, Imaging, and Controlled ReleaseAccounts of Chemical Research, 2013
- Silica-based mesoporous nanoparticles for controlled drug deliveryJournal of Tissue Engineering, 2013
- Efficient Intracellular Delivery of Camptothecin by Silica/Titania Hollow NanoparticlesChemistry – A European Journal, 2012
- Fluorescent hollow/rattle-type mesoporous Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of cancer cellsJournal of Colloid and Interface Science, 2011
- Mesoporous Silica Nanoparticles for Intracellular Controlled Drug DeliverySmall, 2010
- Understanding and Overcoming Major Barriers in Cancer NanomedicineNanomedicine, 2010